QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
NASDAQ:BCPC

Balchem - BCPC Stock Forecast, Price & News

$125.21
-2.56 (-2.00%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$125.05
$128.06
50-Day Range
$113.60
$135.76
52-Week Range
$110.15
$174.29
Volume
90,378 shs
Average Volume
119,267 shs
Market Capitalization
$4.02 billion
P/E Ratio
37.49
Dividend Yield
0.50%
Price Target
$163.50

Balchem MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
30.6% Upside
$163.50 Price Target
Short Interest
Bearish
1.50% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.54
Upright™ Environmental Score
News Sentiment
0.52mentions of Balchem in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$452,358 Sold Last Quarter
Proj. Earnings Growth
3.47%
From $3.46 to $3.58 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.74 out of 5 stars

Basic Materials Sector

32nd out of 166 stocks

Chemicals & Allied Products Industry

4th out of 15 stocks

BCPC stock logo

About Balchem (NASDAQ:BCPC) Stock

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.

Balchem Stock Up 0.2 %

BCPC Stock opened at $127.77 on Tuesday. The firm has a 50 day moving average of $126.34 and a 200 day moving average of $130.99. The stock has a market capitalization of $4.10 billion, a PE ratio of 38.25 and a beta of 0.59. The company has a quick ratio of 1.64, a current ratio of 2.62 and a debt-to-equity ratio of 0.50. Balchem has a 52 week low of $110.15 and a 52 week high of $174.29.

Analysts Set New Price Targets

A number of analysts recently commented on BCPC shares. HC Wainwright lowered their target price on shares of Balchem from $155.00 to $152.00 and set a "buy" rating for the company in a research note on Monday, May 2nd. StockNews.com cut shares of Balchem from a "buy" rating to a "hold" rating in a research note on Monday, August 1st.

Insider Buying and Selling at Balchem

In other Balchem news, VP Gunsteren Job Leonard Van sold 3,601 shares of Balchem stock in a transaction that occurred on Wednesday, August 3rd. The shares were sold at an average price of $125.62, for a total transaction of $452,357.62. Following the completion of the sale, the vice president now directly owns 1,430 shares in the company, valued at approximately $179,636.60. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 1.60% of the company's stock.

Receive BCPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Balchem and its competitors with MarketBeat's FREE daily newsletter.

BCPC Stock News Headlines

StockNews.com Downgrades Balchem (NASDAQ:BCPC) to Hold
Balchem's Earnings: A Preview - Benzinga
Balchem (BCPC) to Release Earnings on Friday
See More Headlines
Receive BCPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Balchem and its competitors with MarketBeat's FREE daily newsletter.

BCPC Company Calendar

Last Earnings
10/28/2021
Today
8/09/2022
Next Earnings (Estimated)
11/04/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
Specialty Chemicals
Current Symbol
NASDAQ:BCPC
CUSIP
05766520
CIK
9326
Employees
1,317
Year Founded
1967

Price Target and Rating

Average Stock Price Forecast
$163.50
High Stock Price Forecast
$175.00
Low Stock Price Forecast
$152.00
Forecasted Upside/Downside
+30.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$96.10 million
Pretax Margin
16.21%

Debt

Sales & Book Value

Annual Sales
$799.02 million
Cash Flow
$4.40 per share
Book Value
$27.08 per share

Miscellaneous

Free Float
31,607,000
Market Cap
$4.02 billion
Optionable
Optionable
Beta
0.59

Social Links


Key Executives

  • Mr. Theodore L. Harris (Age 57)
    Chairman, CEO & Pres
    Comp: $2.87M
  • Mr. Carl Martin Bengtsson (Age 45)
    CFO & Treasurer
    Comp: $992.19k
  • Mr. William A. Backus CPA (Age 56)
    CPA, Chief Accounting Officer
    Comp: $560.79k
  • Mr. Mark A. Stach (Age 60)
    Gen. Counsel & Corp. Sec.
    Comp: $636.75k
  • Mr. James C. Hyde (Age 62)
    Sr. VP and GM of Human Nutrition & Health
    Comp: $805.89k
  • Mr. Martin Luther Reid (Age 55)
    Chief Supply Chain Officer
    Comp: $775.94k
  • Mr. Jonathan Griffin
    Sr. VP and GM of Animal Nutrition & Health













BCPC Stock - Frequently Asked Questions

Should I buy or sell Balchem stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" BCPC shares.
View BCPC analyst ratings
or view top-rated stocks.

What is Balchem's stock price forecast for 2022?

2 Wall Street research analysts have issued 1 year price objectives for Balchem's shares. Their BCPC share price forecasts range from $152.00 to $175.00. On average, they predict the company's share price to reach $163.50 in the next year. This suggests a possible upside of 29.3% from the stock's current price.
View analysts price targets for BCPC
or view top-rated stocks among Wall Street analysts.

How has Balchem's stock performed in 2022?

Balchem's stock was trading at $168.60 on January 1st, 2022. Since then, BCPC shares have decreased by 25.0% and is now trading at $126.43.
View the best growth stocks for 2022 here
.

When is Balchem's next earnings date?

Balchem is scheduled to release its next quarterly earnings announcement on Friday, November 4th 2022.
View our BCPC earnings forecast
.

How were Balchem's earnings last quarter?

Balchem Co. (NASDAQ:BCPC) released its quarterly earnings data on Thursday, October, 28th. The basic materials company reported $0.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.90 by $0.02. The basic materials company earned $197.87 million during the quarter, compared to the consensus estimate of $204.80 million. Balchem had a trailing twelve-month return on equity of 12.84% and a net margin of 12.40%. During the same quarter in the prior year, the company posted $0.83 EPS.

How often does Balchem pay dividends? What is the dividend yield for Balchem?

Balchem declared an annual dividend on Friday, December 17th. Investors of record on Tuesday, December 28th will be given a dividend of $0.64 per share on Friday, January 21st. This represents a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, December 27th. This is a boost from the stock's previous annual dividend of $0.58.
Read our dividend analysis for BCPC
.

Is Balchem a good dividend stock?

Balchem (NASDAQ:BCPC) pays an annual dividend of $0.64 per share and currently has a dividend yield of 0.50%. The company has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 19.16%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BCPC will have a dividend payout ratio of 17.88% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BCPC.

What is Dino A. Rossi's approval rating as Balchem's CEO?

25 employees have rated Balchem Chief Executive Officer Dino A. Rossi on Glassdoor.com. Dino A. Rossi has an approval rating of 85% among the company's employees. 62.0% of employees surveyed would recommend working at Balchem to a friend.

What other stocks do shareholders of Balchem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Ecolab (ECL), CVS Health (CVS), AbbVie (ABBV), Johnson & Johnson (JNJ), Lowe's Companies (LOW), Altria Group (MO), NVIDIA (NVDA), AT&T (T), Analog Devices (ADI) and Bristol-Myers Squibb (BMY).

What is Balchem's stock symbol?

Balchem trades on the NASDAQ under the ticker symbol "BCPC."

Who are Balchem's major shareholders?

Balchem's stock is owned by many different retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (3.14%), Geneva Capital Management LLC (2.17%), Stephens Investment Management Group LLC (1.00%), Pictet Asset Management SA (0.82%), Assenagon Asset Management S.A. (0.40%) and Tributary Capital Management LLC (0.34%). Insiders that own company stock include David F Ludwig, Gunsteren Job Leonard Van, Scott C Mason and William A Backus.
View institutional ownership trends
.

How do I buy shares of Balchem?

Shares of BCPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Balchem's stock price today?

One share of BCPC stock can currently be purchased for approximately $126.43.

How much money does Balchem make?

Balchem (NASDAQ:BCPC) has a market capitalization of $4.06 billion and generates $799.02 million in revenue each year. The basic materials company earns $96.10 million in net income (profit) each year or $3.34 on an earnings per share basis.

How many employees does Balchem have?

Balchem employs 1,317 workers across the globe.

When was Balchem founded?

Balchem was founded in 1967.

How can I contact Balchem?

Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The official website for the company is www.balchem.com. The basic materials company can be reached via phone at (845) 326-5600, via email at mabrush@balchem.com, or via fax at 845-326-5717.

This page (NASDAQ:BCPC) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.